Neritaloside

CAS : 465-13-4

Ref. 3D-AAA46513

Informations sur le produit

• Nom: Neritaloside
• Synonymes: (3β,5β,16β)-16-(Acetyloxy)-3-[(6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</span>-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl-β-<span class="text-smallcaps">D</span>-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β,16β)-, Strospeside, 16-acetate, (3β,5β,16β)-16-(Acetyloxy)-3-[(6-deoxy-3-O-methyl-β-D-galactopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl-β-D-galactopyranosyl)oxy]-14-hydroxy-, (3β,5β,16β)-

Description

Neritaloside is a cardiac glycoside that is classified as a depressant. It is used in the treatment of congestive heart failure and cardiac arrhythmias. Neritaloside has been shown to have neuroprotective effects, which may be due to its ability to inhibit reactive oxygen species and prevent DNA damage. Neritaloside also has been shown to have genotoxic effects, which can lead to cancer. Neritaloside binds to the α subunit of the adenosine receptor and inhibits protein synthesis, leading to cell death by inhibiting protein production vital for cell division. This drug also possesses some anticancer activity, which may be due to its ability to induce apoptosis in cultured cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 592.7 g/mol
• Formule: C₃₂H₄₈O₁₀
• Degré de pureté: Min. 95%